In convolutional neural networks (CNNs), downsampling operations are crucial to model performance. Although traditional downsampling methods (such as maximum pooling and cross-row convolution) perform well in feature aggregation, receptive field expansion, and computational reduction, they may lead to the loss of key spatial information in semantic segmentation tasks, thereby affecting the pixel-by-pixel prediction accuracy.To this end, this study proposes a downsampling method based on information complementarity - Hybrid Pooling Downsampling (HPD). The core is to replace the traditional method with MinMaxPooling, and effectively retain the light and dark contrast and detail features of the image by extracting the maximum value information of the local area.Experiment on various CNN architectures on the ACDC and Synapse datasets show that HPD outperforms traditional methods in segmentation performance, and increases the DSC coefficient by 0.5% on average. The results show that the HPD module provides an efficient solution for semantic segmentation tasks.

Medical radiology reports play a crucial role in diagnosing various diseases, yet generating them manually is time-consuming and burdens clinical workflows. Medical radiology report generation aims to automate this process using deep learning to assist radiologists and reduce patient wait times. This study presents the most comprehensive systematic review to date on deep learning-based MRRG, encompassing recent advances that span traditional architectures to large language models. We focus on available datasets, modeling approaches, and evaluation practices. Following PRISMA guidelines, we retrieved 323 articles from major academic databases and included 78 studies after eligibility screening. We critically analyze key components such as model architectures, loss functions, datasets, evaluation metrics, and optimizers - identifying 22 widely used datasets, 14 evaluation metrics, around 20 loss functions, over 25 visual backbones, and more than 30 textual backbones. To support reproducibility and accelerate future research, we also compile links to modern models, toolkits, and pretrained resources. Our findings provide technical insights and outline future directions to address current limitations, promoting collaboration at the intersection of medical imaging, natural language processing, and deep learning to advance trustworthy AI systems in radiology.

Cardiovascular illnesses continue to be a predominant cause of mortality globally, underscoring the necessity for prompt and precise diagnosis to mitigate consequences and healthcare expenditures. This work presents a complete hybrid methodology that integrates machine learning techniques with medical image analysis to improve the identification of cardiovascular diseases. This research integrates many imaging modalities such as echocardiography, cardiac MRI, and chest radiographs with patient health records, enhancing diagnosis accuracy beyond standard techniques that depend exclusively on numerical clinical data. During the preprocessing phase, essential visual elements are collected from medical pictures utilizing image processing methods and convolutional neural networks (CNNs). These are subsequently integrated with clinical characteristics and input into various machine learning classifiers, including Support Vector Machines (SVM), Random Forest (RF), XGBoost, and Deep Neural Networks (DNNs), to differentiate between healthy persons and patients with cardiovascular illnesses. The proposed method attained a remarkable diagnostic accuracy of up to 96%, exceeding models reliant exclusively on clinical data. This study highlights the capability of integrating artificial intelligence with medical imaging to create a highly accurate and non-invasive diagnostic instrument for cardiovascular disease.

Lymphoma poses a critical health challenge worldwide, demanding computer aided solutions towards diagnosis, treatment, and research to significantly enhance patient outcomes and combat this pervasive disease. Accurate classification of lymphoma subtypes from Whole Slide Images (WSIs) remains a complex challenge due to morphological similarities among subtypes and the limitations of models that fail to jointly capture local and global features. Traditional diagnostic methods, limited by subjectivity and inconsistencies, highlight the need for advanced, Artificial Intelligence (AI)-driven solutions. This study proposes a hybrid deep learning framework-Hybrid Convolutional and Transformer Network for Lymphoma Classification (HCTN-LC)-designed to enhance the precision and interpretability of lymphoma subtype classification. The model employs a dual-pathway architecture that combines a lightweight SqueezeNet for local feature extraction with a Vision Transformer (ViT) for capturing global context. A Feature Fusion and Enhancement Module (FFEM) is introduced to dynamically integrate features from both pathways. The model is trained and evaluated on a large WSI dataset encompassing three lymphoma subtypes: CLL, FL, and MCL. HCTN-LC achieves superior performance with an overall accuracy of 99.87%, sensitivity of 99.87%, specificity of 99.93%, and AUC of 0.9991, outperforming several recent hybrid models. Grad-CAM visualizations confirm the model's focus on diagnostically relevant regions. The proposed HCTN-LC demonstrates strong potential for real-time and low-resource clinical deployment, offering a robust and interpretable AI tool for hematopathological diagnosis.

Medical imaging plays a vital role in early disease diagnosis and monitoring. Specifically, blood microscopy offers valuable insights into blood cell morphology and the detection of hematological disorders. In recent years, deep learning-based automated classification systems have demonstrated high potential in enhancing the accuracy and efficiency of blood image analysis. However, a detailed performance analysis of specific deep learning frameworks appears to be lacking. This paper compares the performance of three popular deep learning frameworks, TensorFlow with Keras, PyTorch, and JAX, in classifying blood cell images from the publicly available BloodMNIST dataset. The study primarily focuses on inference time differences, but also classification performance for different image sizes. The results reveal variations in performance across frameworks, influenced by factors such as image resolution and framework-specific optimizations. Classification accuracy for JAX and PyTorch was comparable to current benchmarks, showcasing the efficiency of these frameworks for medical image classification.

Recent advances in medical image segmentation have been driven by deep learning; however, most existing methods remain limited by modality-specific designs and exhibit poor adaptability to dynamic medical imaging scenarios. The Segment Anything Model 2 (SAM2) and its related variants, which introduce a streaming memory mechanism for real-time video segmentation, present new opportunities for prompt-based, generalizable solutions. Nevertheless, adapting these models to medical video scenarios typically requires large-scale datasets for retraining or transfer learning, leading to high computational costs and the risk of catastrophic forgetting. To address these challenges, we propose DD-SAM2, an efficient adaptation framework for SAM2 that incorporates a Depthwise-Dilated Adapter (DD-Adapter) to enhance multi-scale feature extraction with minimal parameter overhead. This design enables effective fine-tuning of SAM2 on medical videos with limited training data. Unlike existing adapter-based methods focused solely on static images, DD-SAM2 fully exploits SAM2's streaming memory for medical video object tracking and segmentation. Comprehensive evaluations on TrackRad2025 (tumor segmentation) and EchoNet-Dynamic (left ventricle tracking) datasets demonstrate superior performance, achieving Dice scores of 0.93 and 0.97, respectively. To the best of our knowledge, this work provides an initial attempt at systematically exploring adapter-based SAM2 fine-tuning for medical video segmentation and tracking. Code, datasets, and models will be publicly available at https://github.com/apple1986/DD-SAM2.

High intra-pancreatic fat deposition (IPFD) plays an important role in diseases of the pancreas. The intricate anatomy of the pancreas and the surrounding structures has historically made IPFD quantification a challenging measurement to make accurately on radiological images. To take on the challenge, automated IPFD quantification methods using artificial intelligence (AI) have recently been deployed. The aim was to benchmark the current knowledge on the use of AI-based models to measure IPFD automatedly. The search was conducted in the MEDLINE, Embase, Scopus, and IEEE Xplore databases. Studies were eligible if they used AI for both segmentation of the pancreas and quantification of IPFD. The ground truth was manual segmentation by radiologists. When possible, data were pooled statistically using a random-effects model. A total of 12 studies (10 cross-sectional and 2 longitudinal) encompassing more than 50 thousand people were included. Eight of the 12 studies used MRI, whereas four studies employed CT. U-Net model and nnU-Net model were the most frequently used AI-based models. The pooled Dice similarity coefficient of AI-based models in quantifying IPFD was 82.3% (95% confidence interval, 73.5 to 91.1%). The clinical application of AI-based models showed the relevance of high IPFD to acute pancreatitis, pancreatic cancer, and type 2 diabetes mellitus. Current AI-based models for IPFD quantification are suboptimal, as the dissimilarity between AI-based and manual quantification of IPFD is not negligible. Future advancements in fully automated measurements of IPFD will accelerate the accumulation of robust, large-scale evidence on the role of high IPFD in pancreatic diseases. KEY POINTS: Question What is the current evidence on the performance and clinical applicability of artificial intelligence-based models for automated quantification of intra-pancreatic fat deposition? Findings The nnU-Net model achieved the highest Dice similarity coefficient among MRI-based studies, whereas the nnTransfer model demonstrated the highest Dice similarity coefficient in CT-based studies. Clinical relevance Standardisation of reporting on artificial intelligence-based models for the quantification of intra-pancreatic fat deposition will be essential to enhancing the clinical applicability and reliability of artificial intelligence in imaging patients with diseases of the pancreas.

Image-to-image (I2I) translation networks have emerged as promising tools for generating synthetic medical images; however, their clinical reliability and ability to preserve diagnostically relevant features remain underexplored. This study evaluates the performance of state-of-the-art 2D/3D I2I networks for converting ultrasound (US) images to synthetic MRI in prostate cancer (PCa) imaging. The novelty lies in combining radiomics, expert clinical evaluation, and classification performance to comprehensively benchmark these models for potential integration into real-world diagnostic workflows. A dataset of 794 PCa patients was analyzed using ten leading I2I networks to synthesize MRI from US input. Radiomics feature (RF) analysis was performed using Spearman correlation to assess whether high-performing networks (SSIM > 0.85) preserved quantitative imaging biomarkers. A qualitative evaluation by seven experienced physicians assessed the anatomical realism, presence of artifacts, and diagnostic interpretability of synthetic images. Additionally, classification tasks using synthetic images were conducted using two machine learning and one deep learning model to assess the practical diagnostic benefit. Among all networks, 2D-Pix2Pix achieved the highest SSIM (0.855 ± 0.032). RF analysis showed that 76 out of 186 features were preserved post-translation, while the remainder were degraded or lost. Qualitative feedback revealed consistent issues with low-level feature preservation and artifact generation, particularly in lesion-rich regions. These evaluations were conducted to assess whether synthetic MRI retained clinically relevant patterns, supported expert interpretation, and improved diagnostic accuracy. Importantly, classification performance using synthetic MRI significantly exceeded that of US-based input, achieving average accuracy and AUC of ~ 0.93 ± 0.05. Although 2D-Pix2Pix showed the best overall performance in similarity and partial RF preservation, improvements are still required in lesion-level fidelity and artifact suppression. The combination of radiomics, qualitative, and classification analyses offered a holistic view of the current strengths and limitations of I2I models, supporting their potential in clinical applications pending further refinement and validation.

Chronological age, although commonly used in clinical practice, fails to capture individual variations in rates of ageing and physiological decline. Recent advances in artificial intelligence (AI) have transformed the estimation of biological age using various imaging techniques. This Review consolidates AI developments in age prediction across brain, chest, abdominal, bone, and facial imaging using diverse methods, including MRI, CT, x-ray, and photographs. The difference between predicted and chronological age-often referred to as age deviation-is a promising biomarker for assessing health status and predicting disease risk. In this Review, we highlight consistent associations between age deviation and various health outcomes, including mortality risk, cognitive decline, and cardiovascular prognosis. We also discuss the technical challenges in developing unbiased models and ethical considerations for clinical application. This Review highlights the potential of AI-based age estimation in personalised medicine as it offers a non-invasive, interpretable biomarker that could transform health risk assessment and guide preventive interventions.

With the widespread application of machine learning (ML) in the diagnosis and treatment of colorectal cancer (CRC), some studies have investigated the use of ML techniques for the diagnosis of KRAS (Kirsten rat sarcoma) mutation. Nevertheless, there is scarce evidence from evidence-based medicine to substantiate its efficacy. Our study was carried out to systematically review the performance of ML models developed using different modeling approaches, in diagnosing KRAS mutations in CRC. We aim to offer evidence-based foundations for the development and enhancement of future intelligent diagnostic tools. PubMed, Cochrane Library, Embase, and Web of Science were systematically retrieved, with the search cutoff date set to December 22, 2024. The encompassed studies are publicly published research papers that use ML to diagnose KRAS gene mutations in CRC. The risk of bias in the encompassed models was evaluated via the PROBAST (Prediction Model Risk of Bias Assessment Tool). A meta-analysis of the model's concordance index (c-index) was performed, and a bivariate mixed-effects model was used to summarize sensitivity and specificity based on diagnostic contingency tables. A total of 43 studies involving 10,888 patients were included. The modeling variables were derived from clinical characteristics, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography/computed tomography, and pathological histology. In the validation cohort, for the ML model developed based on CT radiomic features, the c-index, sensitivity, and specificity were 0.87 (95% CI 0.84-0.90), 0.85 (95% CI 0.80-0.89), and 0.83 (95% CI 0.73-0.89), respectively. For the model developed using MRI radiomic features, the c-index, sensitivity, and specificity were 0.77 (95% CI 0.71-0.83), 0.78 (95% CI 0.72-0.83), and 0.73 (95% CI 0.63-0.81), respectively. For the ML model developed based on positron emission tomography/computed tomography radiomic features, the c-index, sensitivity, and specificity were 0.84 (95% CI 0.77-0.90), 0.73, and 0.83, respectively. Notably, the deep learning (DL) model based on pathological images demonstrated a c-index, sensitivity, and specificity of 0.96 (95% CI 0.94-0.98), 0.83 (95% CI 0.72-0.91), and 0.87 (95% CI 0.77-0.92), respectively. The DL model MRI-based model showed a c-index of 0.93 (95% CI 0.90-0.96), sensitivity of 0.85 (95% CI 0.75-0.91), and specificity of 0.83 (95% CI 0.77-0.88). ML is highly accurate in diagnosing KRAS mutations in CRC, and DL models based on MRI and pathological images exhibit particularly strong diagnosis accuracy. More broadly applicable DL-based diagnostic tools may be developed in the future. However, the clinical application of DL models remains relatively limited at present. Therefore, future research should focus on increasing sample sizes, improving model architectures, and developing more advanced DL models to facilitate the creation of highly efficient intelligent diagnostic tools for KRAS mutation diagnosis in CRC.